MedTrace Logo

A Study on Telemedicine Applied to Actual Outpatient Clinic for Epilepsy

NCT05418257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 307

Last updated 2024-08-22

No results posted yet for this study

Summary

This is an observational study to confirm the non-inferior effectiveness on health outcomes of tele-counseling or tele-prescription, which was the first outpatient system applied to the actual medical sites in Korea during the coronavirus disease 2019 (COVID-19) pandemic. Researchers collect data using electronic medical records and questionnaires to patients and their caregivers who are continuously receiving outpatient treatment for epilepsy at a single center. The results of the study will be presented by comparing the health outcomes between the non-face-to-face care group and the usual care group.

Conditions

Interventions

OTHER

(exposure) telemedicine

medical counseling or treatment only using phone

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Lee Seuk, M.D. · Samsung Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-16
Primary Completion
2023-05-01
Completion
2023-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05418257 on ClinicalTrials.gov